Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005 HC Wijeysundera, M Machado, F Farahati, X Wang, W Witteman, ... Jama 303 (18), 1841-1847, 2010 | 398 | 2010 |
The economic burden of schizophrenia in Canada in 2004 R Goeree, F Farahati, N Burke, G Blackhouse, D O’Reilly, J Pyne, ... Current medical research and opinion 21 (12), 2017-2028, 2005 | 302 | 2005 |
The effects of parents’ psychiatric disorders on children’s high school dropout F Farahati, DE Marcotte, V Wilcox-Gök Economics of education review 22 (2), 167-178, 2003 | 126 | 2003 |
One size fits some: the impact of patient treatment attitudes on the cost-effectiveness of a depression primary-care intervention JM Pyne, KM Rost, F Farahati, SP Tripathi, J Smith, DK Williams, J Fortney, ... Psychological Medicine 35 (6), 839-854, 2005 | 91 | 2005 |
Resource use and costs of end-of-life/palliative care: Ontario adult cancer patients dying during 2002 and 2003 H Walker, M Anderson, F Farahati, D Howell, SL Librach, A Husain, ... Journal of palliative care 27 (2), 79-88, 2011 | 56 | 2011 |
Early onset depression and high school dropout V Wilcox-Gök, DE Marcotte, F Farahati, C Borkoski The economics of gender and mental illness 15, 27-51, 2004 | 25 | 2004 |
Overview of atypical antipsychotic monotherapy for schizophrenia: clinical review and economic evaluation of first year of treatment [Technology overview number 32] F Farahati, M Boucher, K Moulton, R Williams, N Herrmann, M Silverman, ... Ottawa: Canadian Agency for Drugs and Technologies in Health, 2007 | 16 | 2007 |
The cost-effectiveness of prevention strategies for pressure ulcers in longterm care homes in Ontario: projections of the Ontario pressure ulcer model A Bayoumi, A John-Baptiste, MH Chen, W Chen, F Farahati, M Krahn NHS. Economic Evaluation Database, 2008 | 11 | 2008 |
Human Alpha 1-Proteinase Inhibitor for Patients with Alpha 1-Antitrypsin Deficiency (Technology Report No. 74) S Chen, F Farahati, D Marciniuk, I Mayers, R Boudreau, T Keating Ottawa: Canadian Agency for Drugs and Technologies in Health, 2007 | 6 | 2007 |
Economic spillovers from public investments in medical countermeasures: a case study of a burn debridement product F Farahati, S Nystrom, DR Howell, R Jaffe Disaster Medicine and Public Health Preparedness 11 (6), 711-719, 2017 | 5 | 2017 |
Preference-Weighted Health Status Associated WithSubstance Use-Disorders Treatment JM Pyne, BM Booth, F Farahati, S Tripathi, GR Smith, PR Marques Journal of studies on alcohol 67 (3), 436-444, 2006 | 4 | 2006 |
Economic Spillover Analysis From Public Medical Investments, Using PICO Elements F Farahati SAGE Publications Limited, 2020 | 1 | 2020 |
The Effects of Parents' Psychiatric Disorders on Children's High School Dropout V Wilcox-Gök, F Farahati, DE Marcotte Elsevier, 2003 | 1 | 2003 |
GENDER DIFFERENCES IN PSYCHIATRIC DISORDERS: EFFECTS ON LABOR MARKET OUTCOMES F Farahati, DE Marcotte, V Wilcox-Gök | 1 | 2002 |
Mental health, schooling, and labor market outcomes F Farahati Northern Illinois University, 2001 | 1 | 2001 |
Sage Research Methods Cases: Medicine and Health F Farahati | | 2020 |
Economic Spillovers from Public Medical Countermeasure Investments: A Case Study of NexoBrid® F Farahati, S Nystrom, D Howell, R Jaffe Annals of Global Health 83 (1), 15-15, 2017 | | 2017 |
Ontario IMPACT Model HC Wijeysundera, M Machado, F Farahati, X Wang, W Witteman, ... | | 2010 |
PCV23 REDUCTIONS IN CORONARY HEART DISEASE MORTALITY ASSOCIATED WITH CHANGES IN RISK FACTORS AND TREATMENT UPTAKES IN ONTARIO BETWEEN 1994 AND 2005 H Wijeysundera, M Machado, F Farahati, X Wang, W Witteman, ... Value in Health 3 (13), A153, 2010 | | 2010 |
PMH19 MONOTHERAPYWITH ATYPICAL ANTIPSYCHOTICS FOR SCHIZOPHRENIAS CLINICAL REVIEW AND ECONOMIC EVALUATION OF FIRST TWELVE MONTHS OF TREATMENT F Farahati, M Boucher, R Williams, K Moulton, N Herrmann, S Normandin Value in Health 3 (11), A114, 2008 | | 2008 |